INCENTIVE*][NON-QUALIFIED**] STOCK OPTION AGREEMENTNon-Qualified • January 30th, 2019 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 30th, 2019 Company Industry JurisdictionTHIS AGREEMENT made and entered into as of _______, 20XX, by and between AgeX Therapeutics, Inc., a Delaware corporation (the “Company”), and __________, an employee (the “Employee”) of the Company or of a subsidiary of the Company (hereinafter included within the term “Company”) within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the “Code”),
INCENTIVE*][NON-QUALIFIED**] STOCK OPTION AGREEMENTNon-Qualified • August 29th, 2018 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledAugust 29th, 2018 Company Industry JurisdictionTHIS AGREEMENT made and entered into as of _______, 20XX, by and between OncoCyte Corporation, a California corporation (the “Company”), and __________, an employee (the “Employee”) of the Company or of a subsidiary of the Company (hereinafter included within the term “Company”) within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the “Code”),
INCENTIVE*][NON-QUALIFIED**] STOCK OPTION AGREEMENTNon-Qualified • October 16th, 2017 • Biotime Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 16th, 2017 Company Industry JurisdictionTHIS AGREEMENT made and entered into as of _______, 20XX, by and between AgeX Therapeutics, Inc., a Delaware corporation (the “Company”), and __________, an employee (the “Employee”) of the Company or of a subsidiary of the Company (hereinafter included within the term “Company”) within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the “Code”),